Abstract
Background
With the introduction of neoadjuvant chemoradiotherapy in patients with esophageal carcinoma, nutritional access has become essential to counter deleterious effects of dysphagia. Current NCCN guidelines do not recommend PEG prior to esophagectomy in these patients, but there is little evidence for this recommendation. The objective of this study was to compare outcomes in patients who underwent esophagectomy with or without prior PEG placement.
Methods
We retrospectively reviewed 96 patients who underwent esophagectomy between 2005 and 2012 for esophageal carcinoma. Patients were divided into two groups; Group I (PEG +ve) and Group II (PEG −ve). Patient characteristics, operative variables, and post-operative complications were compared. χ 2 and Fisher’s test were used for categorical, while t test was used for interval variables.
Results
Median age was 51(18–70) years. Lower thoracic tumors were more common in Group I (69 vs. 63 %) (P = 0.04) and more patients underwent minimally invasive surgery in this group (50 vs. 2.6 %) (P < 0.0001). Mean blood loss (326 vs. 465 ml) (P = 0.02) and ICU stay (1.6 vs. 4.3 days) (P = 0.01) were significantly lower in Group I. There was no 30-day mortality in Group I versus 10.5 % in Group II (P = 0.01). No significant difference in anastomotic leak and stricture rate was observed. Gastric conduit was used in all patients for reconstruction. One patient had malignancy in PEG site biopsy.
Conclusion
Percutaneous endoscopic gastrostomy before esophagectomy is safe and does not adversely impact post-operative outcomes.
Similar content being viewed by others
References
Van Hagen P, Hulshof MC, van Lanschot JJ et al (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084
Bozzetti F (2010) Nutritional support in patients with oesophageal cancer. Support Care Cancer 18(Suppl 2):S41–S50
Pearce CB, Duncan HD (2002) Enteral feeding. Nasogastric, nasojejunal, percutaneous endoscopic gastrostomy, or jejunostomy: its indications and limitations. Postgrad Med J 78:198–204
Nagaraja V, Cox MR, Eslick GD (2014) Safety and efficacy of esophageal stents preceding or during neoadjuvant chemotherapy for esophageal cancer: a systematic review and meta-analysis. J Gastrointest Oncol 5:119–126
Ohnmacht GA, Allen MS, Cassivi SD et al (2006) Percutaneous endoscopic gastrostomy risks rendering the gastric conduit unusable for esophagectomy. Dis Esophagus 19:311–312
Wacke W, Hecker U, Woenckhaus C et al (2004) Percutaneous endoscopic gastrostomy site metastasis in a patient with esophageal cancer. Endoscopy 36:472
Cappell MS (2007) Risk factors and risk reduction of malignant seeding of the percutaneous endoscopic gastrostomy track from pharyngoesophageal malignancy: a review of all 44 known reported cases. Am J Gastroenterol 102:1307–1311
Wright GP, Foster SM, Chung MH (2014) Esophagectomy in patients with prior percutaneous endoscopic gastrostomy tube placement. Am J Surg 207:361–365 discussion 364–5
Margolis M, Alexander P, Trachiotis GD et al (2003) Percutaneous endoscopic gastrostomy before multimodality therapy in patients with esophageal cancer. Ann Thorac Surg 76:1694–1697 discussion 1697–8
Rizvi FH, Syed AA, Khattak S, Rizvi SS et al (2014) Complete pathological response after neoadjuvant treatment in locally advanced esophageal cancer predicts long term survival: a retrospective cohort study. Int J Surg 12:621–625
Briel JW, Tamhankar AP, Hagen JA et al (2004) Prevalence and risk factors for ischemia, leak, and stricture of esophageal anastomosis: gastric pull-up versus colon interposition. J Am Coll Surg 198:536–541 discussion 54–2
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhatti, A.B.H., Rizvi, F.H., Waheed, A. et al. Does Prior Percutaneous Endoscopic Gastrostomy Alter Post-operative Outcome After Esophagectomy. World J Surg 39, 441–445 (2015). https://doi.org/10.1007/s00268-014-2812-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-014-2812-8